Patient
P2B-127
completed Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Blokhin Cancer Research Center (Moscow, Russia) (Dr. Moreau)
consented 2013-06-27
Adverse events
1
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 1
severe
assessed
2013-08-16
Grade 3 leukopenia with onset in cycle 2 (2013-08-16); assessed as related to study drug (probable); resolved 2013-08-21.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.